Discover more insights into Neutralization Assay 중화 분석

Keywords frequently search together with Neutralization Assay 중화 분석

Narrow sentence examples with built-in keyword filters

Neutralization Assay sentence examples within enzyme linked immunosorbent



COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools


Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization

Neutralization Assay sentence examples within receptor binding domain



Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S


Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination

Neutralization Assay sentence examples within angiotensin converting enzyme



A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection


A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells



Neutralization Assay sentence examples within plaque reduction neutralization



Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.


Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus

Neutralization Assay sentence examples within laborious time consuming



SARS-CoV-2 Spike Pseudoviruses: A Useful tool to study virus entry and address emerging neutralization escape phenotypes


Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273

Neutralization Assay sentence examples within quant may replace



In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients.


In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients

Neutralization Assay sentence examples within acute respiratory syndrome



SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response


Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies

Neutralization Assay sentence examples within 2 spike pseudotyped



Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2


Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.

Neutralization Assay sentence examples within Viru Neutralization Assay



Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization


Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

Neutralization Assay sentence examples within Pseudoviru Neutralization Assay



A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay


Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples

Neutralization Assay sentence examples within Surrogate Neutralization Assay



Humoral and cellular immune response and safety of two‐dose SARS‐CoV‐2 mRNA‐1273 vaccine in solid organ transplant recipients


A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

Neutralization Assay sentence examples within Reduction Neutralization Assay



West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019


Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection

Neutralization Assay sentence examples within 2 Neutralization Assay



Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection


Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Neutralization Assay sentence examples within Viral Neutralization Assay



Distinct age-specific SARS-CoV-2 IgG decay kinetics following natural infection


Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43

Neutralization Assay sentence examples within Serum Neutralization Assay



Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults


Association of adenovirus 36 and gynecomastia development: A case-control study

Neutralization Assay sentence examples within Toxin Neutralization Assay



Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine


Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model

Neutralization Assay sentence examples within Cytotoxicity Neutralization Assay



Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples.


[Significance of a polymerase chain reaction method in the detection of Clostridioides difficile].

Neutralization Assay sentence examples within Classical Neutralization Assay



Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses


Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Pre-Immune to Seasonal Influenza A Viruses

Neutralization Assay sentence examples within Antibody Neutralization Assay



Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation


The Effects of Ethyl Lauroyl Arginine Hydrochloride (ELAH) in Nasal Spray Formula on SAR-Cov-2

Neutralization Assay sentence examples within Pseudotype Neutralization Assay



Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection


Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection

Neutralization Assay sentence examples within Vivo Neutralization Assay



Development of monoclonal antibody against glycoprotein of hirame novirhabdovirus (HIRRV) with virus neutralizing activity.


Evaluation of the relationship between the 14-3-3ε protein and LvRab11 in the shrimp Litopenaeus vannamei during WSSV infection

Neutralization Assay sentence examples within Throughput Neutralization Assay



Antibody Responses to SARS-CoV-2 after Infection or Vaccination in Children and Young Adults with Inflammatory Bowel Disease


Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012

Neutralization Assay sentence examples within Functional Neutralization Assay



Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates


Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Neutralization Assay sentence examples within Direct Neutralization Assay



In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients.


In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients

Neutralization Assay sentence examples within Vitro Neutralization Assay



Protective Immunity Against Enterotoxigenic Escherichia coli by Oral Vaccination of Engineered Lactococcus lactis


Differential Expression of Three Cryptosporidium Species-Specific MEDLE Proteins

Neutralization Assay sentence examples within Phage Neutralization Assay



Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation


Identification of the receptor-binding protein of Clostridium difficile phage CDHS-1 reveals a new class of receptor-binding domains

Neutralization Assay sentence examples within Quantitative Neutralization Assay



A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection


Standardized Two-Step Testing of Antibody Activity in COVID-19 Convalescent Plasma

Neutralization Assay sentence examples within Effective Neutralization Assay



SARS-CoV-2 Spike Pseudoviruses: A Useful tool to study virus entry and address emerging neutralization escape phenotypes


SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes

Neutralization Assay sentence examples within Using Neutralization Assay



A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants


A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

Neutralization Assay sentence examples within Lentiviru Neutralization Assay



Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2


Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.

Neutralization Assay sentence examples within Rapid Neutralization Assay



Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies


Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Neutralization Assay sentence examples within New Neutralization Assay



Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.


Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens

Neutralization Assay sentence examples within Laboriou Neutralization Assay



Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age


Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age.

Neutralization Assay sentence examples within Psv Neutralization Assay



A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs


Clinical and immunological characteristics in COVID-19 convalescent patients

Neutralization Assay sentence examples within Quality Neutralization Assay



Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples


Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

Neutralization Assay sentence examples within Bl Neutralization Assay



Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth


Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.

Neutralization Assay sentence examples within neutralization assay revealed



Evolution of human antibody responses up to one year after SARS-CoV-2 infection


Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2

Neutralization Assay sentence examples within neutralization assay focusing



Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q


Antibody mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q

Neutralization Assay sentence examples within neutralization assay showed



Development of monoclonal antibody against glycoprotein of hirame novirhabdovirus (HIRRV) with virus neutralizing activity.


Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Neutralization Assay sentence examples within neutralization assay allowed



Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.


Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens

Neutralization Assay sentence examples within neutralization assay format



A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.


RSV neutralization assays - Use in immune response assessment.


Naturally Acquired Antibodies Against Human Papillomavirus are Protective Against Subsequent Homotypic Infection: A Large-Scale Prospective Cohort Study



Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience



Spike protein antibodies mediate the apparent correlation between SARS-CoV-2 nucleocapsid antibodies and neutralization test results



Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis



Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization using a versatile adenovirus-inspired multimerization platform



Identification of potential novel hosts and the risk of infection of lymphocytic choriomeningitis virus in humans in Gabon, Central Africa.



Porcine Circovirus (PCV) Genotype 2d-Based Virus-like Particles (VLPs) Induced Broad Cross-Neutralizing Antibodies against Diverse Genotypes and Provided Protection in Dual-Challenge Infection of a PCV2d Virus and a Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)



The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF)



Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants



COVID‐19 convalescent plasma; time for “goal directed therapy”?



Characterization of an Anti-Ebola virus Hyperimmune Globulin Derived from Convalescent Plasma.



Potential role of naturally acquired immunity against HPV in the control of HPV related diseases



The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.



Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection



Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients



Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City



Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay



Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection


Neutralization Assay 중화 분석


Neutralization Assay 중화 분석
Encyclopedia 백과사전